{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:26:30Z","timestamp":1787498790743,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["KECJ2024012"],"award-info":[{"award-number":["KECJ2024012"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic Fatty Liver Disease (NAFLD) is a prevalent condition characterized by the accumulation of fat in the liver, often linked with increased risk for multi-systemic diseases. This study aims to investigate the relationship between NAFLD and mortality, particularly all-cause and cardiovascular mortality, among United States adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the National Health and Nutrition Examination Survey (NHANES) were utilized, encompassing 80,312 participants from 2003\u20132004 to 2017\u20132018. After exclusions for incomplete data, potential other liver diseases, and significant alcohol consumption, the final analytical cohort included 32,698 participants. The Fatty Liver Index (FLI), a non-invasive diagnostic tool, was used to identify NAFLD. Covariates included demographic characteristics, lifestyle factors, and biochemical parameters. Survival analysis was conducted using a weighted Cox proportional hazards regression model to quantify the impact of NAFLD on mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study revealed that NAFLD was significantly associated with increased risks of all-cause and cardiovascular disease (CVD) mortality. The hazard ratios (HRs) from the survival analysis consistently indicated a higher risk among participants with NAFLD compared to those without. Subgroup analyses further confirmed the association, with notable exceptions in certain subgroups such as those with high school education and diabetes. Additionally, a nonlinear relationship between serum uric acid (SUA) levels and mortality risk was identified among NAFLD participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Non-alcoholic Fatty Liver Disease is a significant risk factor for all-cause and CVD mortality in US adults. The findings underscore the importance of early detection and intervention for NAFLD to mitigate its impact on public health. Further research is needed to explore the complex interactions between NAFLD, SUA levels, and mortality, particularly in high-risk subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2024.1502671","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T23:53:12Z","timestamp":1732233192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults"],"prefix":"10.3389","volume":"11","author":[{"given":"Fen","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/nyas.15012","article-title":"Nonalcoholic liver disease: epidemiology, risk factors, natural history, and management strategies","volume":"1526","author":"Agyapong","year":"2023","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.4254\/wjh.v13.i11.1584","article-title":"Heterogeneity of non-alcoholic fatty liver disease: implications for clinical practice and research activity","volume":"13","author":"Pal","year":"2021","journal-title":"World J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","article-title":"Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e2354277","DOI":"10.1001\/jamanetworkopen.2023.54277","article-title":"Dietary niacin intake and mortality among individuals with nonalcoholic fatty liver disease","volume":"7","author":"Pan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e3497","DOI":"10.1210\/clinem\/dgac190","article-title":"Serum uric acid levels and nonalcoholic fatty liver disease: a 2-sample bidirectional Mendelian randomization study","volume":"107","author":"Li","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1038\/s41598-024-55845-5","article-title":"Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"dgz068","DOI":"10.1210\/clinem\/dgz068","article-title":"U-shaped association of serum uric acid with all-cause and cause-specific mortality in US adults: a cohort study","volume":"105","author":"Hu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/CLEP.S403314","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin Epidemiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11657-023-01356-1","article-title":"Race and ethnic differences in physical activity, osteopenia, and osteoporosis: results from NHANES 2009-2010, 2013-2014, 2017-2018","volume":"19","author":"V\u00e1squez","year":"2023","journal-title":"Arch Osteoporos"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21101\/cejph.a6276","article-title":"Association between cholesterol intake and all-cause mortality: NHANES-linked mortality study","volume":"29","author":"Du","year":"2021","journal-title":"Cent Eur J Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"140602","DOI":"10.1016\/j.chemosphere.2023.140602","article-title":"Using machine learning methods to analyze the association between urinary polycyclic aromatic hydrocarbons and chronic bowel disorders in American adults","volume":"346","author":"Zang","year":"2024","journal-title":"Chemosphere"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3727\/105221619X15553433838609","article-title":"Nonalcoholic fatty liver disease: an update on the diagnosis","volume":"19","author":"Zhang","year":"2019","journal-title":"Gene Expr"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts","volume":"24","author":"Papatheodoridi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2023.17935","article-title":"Diagnosis and Management of Nonalcoholic Fatty Liver Disease","volume":"330","author":"Leung","year":"2023","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"100896","DOI":"10.1016\/j.jhepr.2023.100896","article-title":"Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease","volume":"5","author":"Ho","year":"2023","journal-title":"JHEP Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.dld.2023.09.024","article-title":"Association between dietary inflammatory index and risk of fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Zhao","year":"2024","journal-title":"Dig Liver Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13105-023-00991-z","article-title":"Fatty liver index (FLI): more than a marker of hepatic steatosis","volume":"80","author":"Kaneva","year":"2024","journal-title":"J Physiol Biochem"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population-based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12966-024-01654-y","article-title":"Associations of daily eating frequency and nighttime fasting duration with biological aging in National Health and nutrition examination survey (NHANES) 2003\u20132010 and 2015\u20132018","volume":"21","author":"Wang","year":"2024","journal-title":"Int J Behav Nutr Phys Act"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12561-018-09229-9","article-title":"Organizing and analyzing the activity data in NHANES","volume":"11","author":"Leroux","year":"2019","journal-title":"Stat Biosci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/LVT.0000000000000148","article-title":"Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US","volume":"29","author":"Lim","year":"2023","journal-title":"Liver Transpl"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/liv.15856","article-title":"Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults","volume":"44","author":"Song","year":"2024","journal-title":"Liver Int"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12020-023-03351-5","article-title":"Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis","volume":"85","author":"Huang","year":"2024","journal-title":"Endocrine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1240099","DOI":"10.3389\/fendo.2023.1240099","article-title":"Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction","volume":"14","author":"Heerkens","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.3390\/diagnostics13213316","article-title":"The role of the fatty liver index (FLI) in the management of non-alcoholic fatty liver disease: a systematic review","volume":"13","author":"Biciusca","year":"2023","journal-title":"Diagnostics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12889-024-18189-3","article-title":"Analysis of the association between urinary glyphosate exposure and fatty liver index: a study for US adults","volume":"24","author":"Han","year":"2024","journal-title":"BMC Public Health"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with Long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1097\/TP.0000000000004603","article-title":"Long-term outcome of asymptomatic patients with graft fibrosis in protocol biopsies after pediatric liver transplantation","volume":"107","author":"Hartleif","year":"2023","journal-title":"Transplantation"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2197652","DOI":"10.1080\/07853890.2023.2197652","article-title":"The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease","volume":"55","author":"Zhao","year":"2023","journal-title":"Ann Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41387-024-00261-x","article-title":"The prognostic role of diet quality in patients with MAFLD and physical activity: data from NHANES","volume":"14","author":"Huang","year":"2024","journal-title":"Nutr Diabet"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/liv.15674","article-title":"The NAFLD burden on mortality and morbidities in general population: a community-based longitudinal study (NASH-CO study)","volume":"43","author":"Nabi","year":"2023","journal-title":"Liver Int"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"01","DOI":"10.1152\/physiol.00013.2023","article-title":"NAFLD: an emerging causal factor for cardiovascular disease","volume":"38","author":"Li","year":"2023","journal-title":"Physiology (Bethesda)"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1038\/s41598-020-63134-0","article-title":"Association between serum uric acid levels and mortality: a nationwide community-based cohort study","volume":"10","author":"Konta","year":"2020","journal-title":"Sci Rep"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1502671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T23:53:15Z","timestamp":1732233195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1502671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":53,"alternative-id":["10.3389\/fnut.2024.1502671"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1502671","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1502671"}}